GH Research Reports Full Year 2024 Financial Results and Provides Business Updates
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for completion of last patient visit in the open-label extension in Q1 2025Phase 1 clinical trial to evaluate ...
manilatimes23h
First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer
Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that the first patient has been successfully dosed in the Phase III ...
CenExel Research: CenExel Supports Metsera, Inc. in Successful Phase II Trial of MET-097 for Obesity and Metabolic Diseases
SALT LAKE CITY, UTAH / ACCESS Newswire / February 27, 2025 / CenExel is pleased to announce its partnership with Metsera, Inc., a clinical-stage biopharmaceutical company dedicated to advancing treatm ...
IRLAB Therapeutics: IRLAB Publishes Phase IIb Data on Mesdopetam in Movement Disorders Clinical Practice
GOTHENBURG, SWEDEN / ACCESS Newswire / February 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a compa ...
Khaleej Times on MSN16h
India on the verge of becoming clinical trials hub
HYDERABAD: India is ready to step in as an alternative site for early-stage clinical trials to help mitigate the impact of ...
manilatimes16h
IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...
Celerion to relocate Belfast clinical research operations to new £64m iREACH Health complex
THE US headquartered clinical research firm Celerion has announced it will relocate its Belfast operation to the new Queen’s ...
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch– First ...
Healio12h
Comorbidities linked to early discontinuation of disease-modifying therapy trials for MS
A higher comorbidity burden was linked to an increased rate of adverse events as well as early discontinuation among patients ...
clubofmozambique.com21h
India on the verge of becoming clinical trials hub, Parexel executive says
India is ready to step in as an alternative site for early-stage clinical trials to help mitigate the impact of disruptions such as the Russia-Ukraine war, an executive at contract research firm ...
UNE professor develops new test for breast cancer
A blood test developed at the University of New England could help more women survive one of the most aggressive forms of ...
Pharmabiz21h
Bayer presents positive results from phase III study QUANTI CNS of gadoquatrane at ECR 2025
Bayer presents positive results from phase III study QUANTI CNS of gadoquatrane at ECR 2025: Berlin Thursday, February 27, 2025, 14:00 Hrs [IST] Bayer, a global leader in radiolog ...